Other Glivec/Gleevec Indicated Hematological Disorders (HES, CEL, MDS/ MPN)
1 clinical trials · Condition
◉ Watch Other Glivec/Gleevec Indicated Hematological Disorders (HES, CEL, MDS/ MPN)
| Record | Firm | Date |
|---|---|---|
| Glivec/Gleevec Pediatric (Age 1 to Less Than 4) PK Study in CML, Ph+ ALL Patients and Other Glivec/Gleevec® Indicated Hematological Disorders. (NCT01066468) | Novartis Pharmaceuticals | 2010-10-01 |
Track Other Glivec/Gleevec Indicated Hematological Disorders (HES, CEL, MDS/ MPN) automatically
Every clearance here is in the API, with alerts when new ones post.